Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hunt

Showing results (861-870 of 886) with videos related to

Pageof 89
Sort By:
Open Forum Infectious Diseases|October 27, 2025
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 WeeksJonathan C Reed, Luke Hall, Ashley McKhann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2024
Mpox in People With Human Immunodeficiency Virus: Predictors of Diagnosis, Outcomes, and Vaccine Effectiveness in a Multisite CohortMichalina Montaño, Adrienne E Shapiro, Bridget M Whitney, et al.
Journal of Medicinal Chemistry|March 30, 2013
Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher speciesKevin W Hunt, Adam W Cook, Ryan J Watts, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Immune activation during broadly neutralizing antibody-mediated HIV suppression prior to post-intervention controlJulia A Wagner, Demi A Sandel, Ravi K Patel, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the USR A Bender Ignacio, A E Shapiro, R M Nance, et al.
BMC Medicine|August 1, 2019
Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)Matthew J Feinstein, Robin M Nance, J A Chris Delaney, et al.
Lancet (London, England)|February 21, 2019
Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trialMary Ellen McCann, Jurgen C de Graaff, Liam Dorris, et al.
AIDS (London, England)|December 18, 2024
Cumulative HIV viral load and lower CD4 + cell count are associated with incident venous thromboembolism in people with HIVStephanie A Ruderman, Robin M Nance, Heidi M Crane, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 14, 2022
Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 InfectionMichael J Peluso, Hannah M Sans, Carrie A Forman, et al.
Journal of Medicinal Chemistry|January 9, 2014
Discovery of 7-tetrahydropyran-2-yl chromans: β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloid β-protein (Aβ) in the central nervous systemAllen A Thomas, Kevin W Hunt, Matthew Volgraf, et al.
Pageof 89

Showing results (861-870 of 886) with videos related to

Sort By:
Pageof 89
Open Forum Infectious Diseases|October 27, 2025
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 WeeksJonathan C Reed, Luke Hall, Ashley McKhann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2024
Mpox in People With Human Immunodeficiency Virus: Predictors of Diagnosis, Outcomes, and Vaccine Effectiveness in a Multisite CohortMichalina Montaño, Adrienne E Shapiro, Bridget M Whitney, et al.
Journal of Medicinal Chemistry|March 30, 2013
Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher speciesKevin W Hunt, Adam W Cook, Ryan J Watts, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Immune activation during broadly neutralizing antibody-mediated HIV suppression prior to post-intervention controlJulia A Wagner, Demi A Sandel, Ravi K Patel, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the USR A Bender Ignacio, A E Shapiro, R M Nance, et al.
BMC Medicine|August 1, 2019
Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)Matthew J Feinstein, Robin M Nance, J A Chris Delaney, et al.
Lancet (London, England)|February 21, 2019
Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trialMary Ellen McCann, Jurgen C de Graaff, Liam Dorris, et al.
AIDS (London, England)|December 18, 2024
Cumulative HIV viral load and lower CD4 + cell count are associated with incident venous thromboembolism in people with HIVStephanie A Ruderman, Robin M Nance, Heidi M Crane, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 14, 2022
Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 InfectionMichael J Peluso, Hannah M Sans, Carrie A Forman, et al.
Journal of Medicinal Chemistry|January 9, 2014
Discovery of 7-tetrahydropyran-2-yl chromans: β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloid β-protein (Aβ) in the central nervous systemAllen A Thomas, Kevin W Hunt, Matthew Volgraf, et al.
Pageof 89